163 related articles for article (PubMed ID: 31835787)
1. Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice.
Chen YH; Wang V; Huang EY; Chou YC; Kuo TT; Olson L; Hoffer BJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835787
[TBL] [Abstract][Full Text] [Related]
2. Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.
Chen YH; Hsieh TH; Kuo TT; Kao JH; Ma KH; Huang EY; Chou YC; Olson L; Hoffer BJ
J Neurochem; 2019 Jul; 150(1):56-73. PubMed ID: 30933310
[TBL] [Abstract][Full Text] [Related]
3. Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.
Lai JH; Chen KY; Wu JC; Olson L; Brené S; Huang CZ; Chen YH; Kang SJ; Ma KH; Hoffer BJ; Hsieh TH; Chiang YH
Brain Res; 2019 Oct; 1720():146301. PubMed ID: 31226324
[TBL] [Abstract][Full Text] [Related]
4. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.
Good CH; Hoffman AF; Hoffer BJ; Chefer VI; Shippenberg TS; Bäckman CM; Larsson NG; Olson L; Gellhaar S; Galter D; Lupica CR
FASEB J; 2011 Apr; 25(4):1333-44. PubMed ID: 21233488
[TBL] [Abstract][Full Text] [Related]
5. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
Quesada A; Micevych PE
J Neurosci Res; 2004 Jan; 75(1):107-16. PubMed ID: 14689453
[TBL] [Abstract][Full Text] [Related]
6. Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson's disease.
Fifel K; Cooper HM
Neurobiol Dis; 2014 Nov; 71():359-69. PubMed ID: 25171792
[TBL] [Abstract][Full Text] [Related]
7. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
8. Neuronal nicotinic receptor agonists ameliorate spontaneous motor asymmetries and motor discoordination in a unilateral mouse model of Parkinson's disease.
Kucinski A; Wersinger S; Stachowiak EK; Corso TD; Parry MJ; Zhang J; Jordan K; Letchworth S; Bencherif M; Stachowiak MK
Pharmacol Biochem Behav; 2013 Oct; 111():1-10. PubMed ID: 23872135
[TBL] [Abstract][Full Text] [Related]
9. Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model.
Lynch WB; Tschumi CW; Sharpe AL; Branch SY; Chen C; Ge G; Li S; Beckstead MJ
Mov Disord; 2018 Dec; 33(12):1928-1937. PubMed ID: 30440089
[TBL] [Abstract][Full Text] [Related]
10. L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history.
Shan L; Diaz O; Zhang Y; Ladenheim B; Cadet JL; Chiang YH; Olson L; Hoffer BJ; Bäckman CM
Brain Res; 2015 Aug; 1618():261-9. PubMed ID: 26086365
[TBL] [Abstract][Full Text] [Related]
11. MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease.
Galter D; Pernold K; Yoshitake T; Lindqvist E; Hoffer B; Kehr J; Larsson NG; Olson L
Genes Brain Behav; 2010 Mar; 9(2):173-81. PubMed ID: 20002202
[TBL] [Abstract][Full Text] [Related]
12. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
13. Chronic L-DOPA induces hyperactivity, normalization of gait and dyskinetic behavior in MitoPark mice.
Gellhaar S; Marcellino D; Abrams MB; Galter D
Genes Brain Behav; 2015 Mar; 14(3):260-70. PubMed ID: 25752644
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
[TBL] [Abstract][Full Text] [Related]
15. Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys.
Tao Y; Vermilyea SC; Zammit M; Lu J; Olsen M; Metzger JM; Yao L; Chen Y; Phillips S; Holden JE; Bondarenko V; Block WF; Barnhart TE; Schultz-Darken N; Brunner K; Simmons H; Christian BT; Emborg ME; Zhang SC
Nat Med; 2021 Apr; 27(4):632-639. PubMed ID: 33649496
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.
Kozina EA; Khakimova GR; Khaindrava VG; Kucheryanu VG; Vorobyeva NE; Krasnov AN; Georgieva SG; Kerkerian-Le Goff L; Ugrumov MV
J Neurol Sci; 2014 May; 340(1-2):198-207. PubMed ID: 24768159
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.
Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T
Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189
[TBL] [Abstract][Full Text] [Related]
18. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.
Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K
Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635
[TBL] [Abstract][Full Text] [Related]
19. Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
Metz GA; Piecharka DM; Kleim JA; Whishaw IQ
Brain Res; 2004 Nov; 1026(1):126-35. PubMed ID: 15476704
[TBL] [Abstract][Full Text] [Related]
20. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
